Windtree Therapeutics, Inc.

WINT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$28,085-$10,631-$4,045$2,767
Dep. & Amort.$360$17$17-$293
Deferred Tax-$3,226$0$0$0
Stock-Based Comp.$17$32$72$21
Change in WC-$2,692$1,201$1,491$809
Other Non-Cash$27,254$6,724$58-$6,989
Operating Cash Flow-$6,372-$2,657-$2,407-$3,685
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$789-$5,183$0$0
Investing Cash Flow-$789-$5,183$0$0
Financing Activities
Debt Repay.$0$1,738$84$89
Stock Issued-$312$5,231$0-$4,177
Stock Repurch.$483$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$6,892$0$2,290$8,591
Financing Cash Flow$7,063$6,969$1,801$3,164
Forex Effect$1$0$0$0
Net Chg. in Cash-$97-$871-$606-$521
Supplemental Information
Beg. Cash$311$1,182$1,788$2,309
End Cash$214$311$1,182$1,788
Free Cash Flow-$6,372-$2,657-$2,407-$3,685
Windtree Therapeutics, Inc. (WINT) Financial Statements & Key Stats | AlphaPilot